CPT code 58951 represents an extensive open abdominal cytoreductive surgery for ovarian, tubal, or primary peritoneal malignancy. The procedure combines bilateral salpingo-oophorectomy, hysterectomy, omentectomy, pelvic lymphadenectomy, and limited para-aortic lymph node dissection performed through an abdominal incision. This code is clinically significant due to its use in primary treatment of advanced gynecologic malignancies and its implications for hospital resource use, perioperative complexity, and postoperative care.

Key payers in the national analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical context of CPT code 58951, typical sites of service, and the kinds of benchmarks and policy considerations tied to high-complexity gynecologic oncology procedures. The publication covers coding and billing practice implications, common modifier usage patterns where applicable, and how payers approach coverage and medical necessity for extensive cytoreductive surgery. It also provides a concise clinical summary to support correct code selection and to inform revenue cycle and utilization review stakeholders.

Data not available in the input for associated taxonomies, specific ICD-10 diagnoses, and payer-specific fee benchmarks.